Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON tablets to treat peripheral circulatory disorder; CORALAN for treatment of chronic heart failure; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; ONGENTYS tablets for the treatment of Parkinson's disease; PARSABIV, an intravenous injection for dialysis patients; STAYBLA tablets for overactive bladder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as RECALBON tablets for osteoporosis. In addition, it is developing products for esophageal, urothelial carcinoma, Hodgkin's lymphoma, ovarian, bladder, prostate, hepatocellular carcinoma, pancreatic, biliary tract, virus positive/negative solid carcinoma, gastric, esophageal, urothelial, hepatocellular, thyroid, colorectal, melanoma, acute myeloid leukemia, non-small cell lung cancer, primary central nervous system lymphoma, myelodysplastic syndrome, polymyositis/dermatomyositis, tachyarrhythmia, pemphigus, generalized scleroderma, enthesopathy, diabetic polyneuropathy, neurodegenerative, autoimmune, narcolepsy, and thrombosis. The company was founded in 1717 and is headquartered in Osaka, Japan.
Ono Pharmaceutical Dividend Announcement
• Ono Pharmaceutical announced a semi annually dividend of $0.09 per ordinary share which will be made payable on 2023-12-18. Ex dividend date: 2023-09-28
• Ono Pharmaceutical annual dividend for 2023 was $0.18
• Ono Pharmaceutical's trailing twelve-month (TTM) dividend yield is -%
• Ono Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 31.25%
• Ono Pharmaceutical's dividend growth over the last five years (2018-2023) was 6.87% year
• Ono Pharmaceutical's dividend growth over the last ten years (2013-2023) was -21.01% year
Ono Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-09-28 | $0.09 | semi annually | 2023-12-18 |
2023-03-30 | $0.09 | semi annually | 2023-07-10 |
2022-09-29 | $0.08 | semi annually | 2022-12-16 |
2022-03-29 | $0.07 | semi annually | 2022-07-11 |
2021-09-28 | $0.08 | semi annually | 2021-09-29 |
2021-03-29 | $0.08 | semi annually | 2021-07-06 |
2020-09-28 | $0.07 | semi annually | 2020-12-16 |
2020-03-27 | $0.07 | semi annually | 2020-07-06 |
2019-09-26 | $0.07 | semi annually | 2019-12-17 |
2019-03-28 | $0.07 | semi annually | 2019-07-08 |
2018-09-27 | $0.07 | semi annually | 2018-12-18 |
2018-03-28 | $0.06 | semi annually | 2018-07-10 |
2017-09-28 | $0.07 | semi annually | 2017-12-18 |
2017-03-28 | $0.06 | semi annually | 2017-07-17 |
2016-09-27 | $0.06 | semi annually | |
2016-03-28 | $0.17 | semi annually | |
2015-09-25 | $0.15 | semi annually | |
2015-03-26 | $0.15 | semi annually | |
2014-09-25 | $0.15 | semi annually | |
2014-03-26 | $0.89 | semi annually | |
2013-09-25 | $0.95 | semi annually | |
2013-03-26 | $0.91 | semi annually | |
2012-12-18 | $1.37 | semi annually |
Ono Pharmaceutical Dividend per year
Ono Pharmaceutical Dividend growth
Ono Pharmaceutical Dividend Yield
Ono Pharmaceutical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ono Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Ono Pharmaceutical Financial Ratios
Ono Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Ono Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Ono Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Ono Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Ono Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Ono Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Ono Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Ono Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Ono Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Ono Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Ono Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Ono Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.